Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats

Epilepsy Research

Volumn 31, Issue 2, 1998, Pages 101-112

  Otsuki, Kenro ^a   Morimoto, Kiyoshi ^b   Sato, Keiko ^c   Yamada, Norihito ^a   Kuroda, Shigetoshi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c National Minamiokayama Hospital   (Japan)

Author keywords

Amygdala; Anticonvulsant; Hippocampus; Kindling; Lamotrigine

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

AMYGDALOID NUCLEUS; ANIMAL MODEL; ANTICONVULSANT THERAPY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROENCEPHALOGRAM; EPILEPSY; EXPERIMENTAL MODEL; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; TREATMENT OUTCOME;

AMYGDALA; ANIMALS; ANTICONVULSANTS; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; KINDLING, NEUROLOGIC; MALE; PHENYTOIN; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; TRIAZINES;

EID: 0031877925     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00018-7     Document Type: Article

References (33)

1. Binnie C.D., Debets R.M., Engelsman M.et al. Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res. 4:1989;222-229.
2. Birnstiel S., Haas H.L. Anticonvulsants do not suppress long-term potentiation (LTP) in the rat hippocampus. Neurosci. Lett. 14:1991;61-63.
3. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
4. Callaghan D.A., Schwark W.S. Pharmacological modification of amygdaloid-kindled seizures. Neuropharmacology. 19:1980;1131-1136.
5. Cohen A.F., Land G.S., Breimer D.D., Yuen W.C., Winton C., Peck A.W. Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans. Clin. Pharmacol. Ther. 42:1987;535-541.
6. Coulter D.A., Huguenard J.R., Prince D.A. Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann. Neurol. 25:1989;582-593.
7. During M.J., Spencer D.D. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain (see comments). Lancet. 341:1993;1607-1610.
8. Ehle A.L. Effects of phenytoin on amygdaloid kindled seizures in the rat. Electroencephalogr. Clin. Neurophysiol. 48:1980;102-105.
9. +-evoked release of L-glutamate in entorhinal kindled rats. Brain Res. 442:1988;368-372.
10. Griffith W.H., Taylor L. Phenytoin reduces excitatory synaptic transmission and post-tetanic potentiation in the in vitro hippocampus. J. Pharmacol. Exp. Ther. 246:1988;851-858.
11. Jawad S., Richens A., Goodwin G., Yuen W.C. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia. 30:1989;356-363.
12. Leach M.J., Marden C.M., Miller A.A. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia. 27:1986;490-497.
13. Lorge M. Erfahrungen mit einem neuen Antiepilepticum, Tegtetol (G 32883), mit besonderer Wirkung auf die epileptische WesensverSnderung. Schweiz Med. Wochensch. 93:1963;1042-1047.
14. Löscher W. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem. Res. 18:1993;485-502.
15. McNamara J.O., Rigsbee L.C., Butler L.S., Shin C. Intravenous phenytoin is an effective anticonvulsant in the kindling model. Ann. Neurol. 26:1989;675-678.
16. Messenheimer J.A. Lamotrigine. Epilepsia. 36(Suppl. 2):1995;87-94.
17. Miller A.A., Wheatley P., Sawyer D.A., Baxter M.G., Roth B. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I. Anticonvulsant profile in mice and rats. Epilepsia. 27:1986;483-489.
18. Morimoto K., Katayama K., Inoue K., Sato K. Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP. Pharmacol. Biochem. Behav. 40:1991;893-899.
19. Morimoto K., Sato H., Yamamoto Y., Watanabe T., Suwaki H. Antiepileptic effects of Tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy. Epilepsia. 38:1997;966-974.
20. Namba T., Morimoto K., Sato K., Yamada N., Kuroda S. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the kindling model of epilepsy. Brain Res. 638:1994;36-44.
21. O'Donnell R.A., Miller A.A. The effect of lamotrigine upon development of cortical kindled seizures in the rat. Neuropharmacology. 30:1991;253-258.
22. Peck, A.W., 1991. Clinical pharmacology of lamotrigine. Epilepsia 32 (Suppl. 2), S9-S12.
23. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
24. Richens A., Dunlop A. Serum phenytoin levels in the management of epilepsy. Lancet. 2:1975;247-248.
25. Sato K., Morimoto M., Okamoto M. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy. Brain Res. 463:1988;12-20.
26. Schlumberger E., Chavez F., Palacios L., Rey E., Pajot N., Dulac O. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia. 35:1994;359-367.
27. Teyler T.J., DiScenna P. Long-term potentiation. Annu. Rev. Neurosci. 10:1987;131-161.
28. Thompson P., Huppert F.A., Trimble M. Phenytoin and cognitive function: effects on normal volunteers and implications for epilepsy. Br. J. Clin. Psychol. 20:1981;155-162.
29. Ueda Y., Tsuru N. Simultaneous monitoring of the seizure-related changes in extracellular glutamate and gamma-aminobutyric acid concentration in bilateral hippocampi following development of amygdaloid kindling. Epilepsy Res. 20:1995;213-219.
30. Wheatley P.L., Miller A.A. Effects of lamotrigine on electrically induced afterdischarge duration in anaesthetised rat, dog, and marmoset. Epilepsia. 30:1989;34-40.
31. Wilder, B.J., 1995. Phenytoin clinical use. In: Rene, H.L., Richard, H.M., Brain, S.M. (Eds.), Antiepileptic Drugs, 4th ed. Raven Press, New York, pp. 339-344.
32. Yaari Y., Selzer M.E., Pincus J.H. Phenytoin: mechanisms of its anticonvulsant action. Ann. Neurol. 20:1986;171-184.
33. Yuen, A.W., 1994. Lamotrigine: a review of antiepileptic efficacy. Epilepsia 35 (Suppl. 5), S33-S36.